Country | Inject | Smoke/inhale | Eat/drink | Sniff | Others | Route known (n) | Route unknown | |
---|---|---|---|---|---|---|---|---|
Belgium | 4.0 | 18.6 | 0.8 | 76.7 | 0.0 | 377 | 18 | |
Bulgaria | 25.0 | 12.5 | 0.0 | 62.5 | 0.0 | 8 | 0 | |
Czech Republic | 0.0 | 0.0 | 0.0 | 100.0 | 0.0 | 10 | 0 | |
Denmark | 10.1 | 6.9 | 2.5 | 80.5 | 0.0 | 159 | 23 | |
Germany | 18.5 | 26.4 | 1.6 | 53.0 | 0.5 | 10901 | : | |
Estonia | : | : | : | : | : | : | : | |
Ireland | 1 | 1.0 | 13.5 | 1.2 | 84.3 | 0.0 | 511 | 2 |
Greece | 10.6 | 33.5 | 1.2 | 54.7 | 0.0 | 161 | 0 | |
Spain | 1 | 2.3 | 14.6 | 1.5 | 81.0 | 0.6 | 21207 | 924 |
France | 8.9 | 34.7 | 0.8 | 55.2 | 0.4 | 1880 | 386 | |
Italy | 2 | 5.3 | 34.0 | 0.4 | 59.9 | 0.4 | 9784 | 487 |
Cyprus | 0.0 | 46.7 | 1.3 | 52.0 | 0.0 | 75 | 0 | |
Latvia | 3 | 0.0 | 0.0 | 0.0 | 100.0 | 0.0 | 5 | 2 |
Lithuania | : | : | : | : | : | : | : | |
Luxembourg | 100.0 | : | : | : | : | 1 | : | |
Hungary | 0.0 | 3.6 | 10.7 | 85.7 | 0.0 | 56 | 3 | |
Malta | 24.8 | 15.9 | 1.3 | 54.9 | 3.1 | 226 | 2 | |
Netherlands | 0.2 | 31.4 | 0.6 | 67.8 | 0.0 | 1791 | 938 | |
Austria | 5.8 | 3.2 | 1.9 | 89.0 | 0.0 | 155 | 4 | |
Poland | 4 | : | 9.1 | 18.2 | 72.7 | : | 11 | : |
Portugal | 5 | 3.6 | 74.8 | 0.5 | 20.7 | 0.5 | 222 | 175 |
Romania | 0.0 | 33.3 | 0.0 | 66.7 | 0.0 | 3 | 0 | |
Slovenia | 44.4 | 16.7 | : | 38.9 | : | 18 | : | |
Slovakia | 0.0 | 0.0 | 0.0 | 100.0 | 0.0 | 6 | 0 | |
Finland | : | : | : | : | : | : | 1 | |
Sweden | 1 | 0.0 | 16.7 | 5.6 | 77.8 | 0.0 | 18 | 1 |
United Kingdom | 6 | 1.9 | 37.3 | 2.2 | 57.9 | 0.7 | 13217 | 379 |
Croatia | 1.8 | 0.0 | 0.0 | 98.2 | : | 112 | 4 | |
Turkey | : | : | : | : | : | : | : | |
Norway | 7 | 0.0 | 0.0 | 0.0 | 100.0 | 0.0 | 2 | 0 |
Total | 5.9 | 26.1 | 1.4 | 66.0 | 0.5 | 60916 | 3349 |
: Indicates no data are available.
Percentages are of clients whose route of administration is known (n)
1 - Data are from 2010.
2 - In 2010 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.
3 - In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.
4 - Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.
5 - In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.
6 - Data are from 1st of April 2010 to 31st March 2011.
7 - In Norway the criteria for selecting and grouping cases are main ICD-10 diagnosis codes F11-F16 and F18-F19.
For more information relative to the treatment centre type, please see Table TDI-7.
See also 'General notes for interpreting data' on the Explanatory notes and help page.
Reitox national reports 2012 — TDI — outpatient treatment centres.